✦ LIBER ✦

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

✍ Scribed by Zhiwei Sui; Quanjiao Chen; Fang Fang; Mei Zheng; Ze Chen

Book ID: 116963070
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 394 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.09.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cross-protection against influenza virus

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

✍ Zhiwei Sui; Quanjiao Chen; Rui Wu; Hongbo Zhang; Mei Zheng; Hanzhong Wang; Ze Ch 📂 Article 📅 2010 🏛 Springer Vienna 🌐 English ⚖ 317 KB

Protection against influenza virus infec

Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant

✍ Hideki Hasegawa; Takeshi Ichinohe; Peter Strong; Izumi Watanabe; Satoshi Ito; Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract Chitin in the form of microparticles (chitin microparticles, CMP) has been demonstrated to be a potent stimulator of macrophages, promoting T‐helper‐1 (Th1) activation and cytokine response. In order to examine the mucosal adjuvant effect of CMP co‐administered with influenza hemaggluti

Protection against influenza virus infec

Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant

✍ Takeshi Ichinohe; Izumi Watanabe; Eriko Tao; Satoshi Ito; Akira Kawaguchi; Shin- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

A safe and effective adjuvant is necessary to enhance mucosal immune responses for the development of an inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of surf clam microparticles (SMP) derived from natural surf clams as an adjuvant for an intranasal influ

Effects of frequent intranasal administr

Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection

✍ Shin-ichi Tamura; Ayako Yajima; Emiko Hatori; Shu Tamura; Hideki Asanuma; Yujiro 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 844 KB

Intranasal immunization with live attenu

Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge

✍ Xueliang Wang, Wenjie Zhang, Fen Liu, Mei Zheng, Dan Zheng, Tao Zhang, Yinglei Y 📂 Article 📅 2012 🏛 Springer Vienna 🌐 English ⚖ 305 KB

Induction of cross-protective immunity a

Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia

✍ Takeshi Ichinohe; Akira Ainai; Tomoyuki Nakamura; Yukihito Akiyama; Jun-ichi Mae 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract The identification of a safe and effective adjuvant that is able to enhance mucosal immune responses is necessary for the development of an efficient inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of extracts of mycelia derived from edible mus